AUC value with ROC curves for KRAS was 0.643 in all patients, 0.649 in patients with early CRC (Stage I) and 0.625 in patients with advanced CRC (Stage II/III) (Figures 2D–F). This evidence concerns the gene KRAS and colorectal carcinoma.